Curbstone Financial Management Corp’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Buy
24,914
+850
+4% +$99.5K 0.55% 44
2026
Q1
$2.89M Buy
24,064
+200
+0.8% +$23.1K 0.55% 45
2025
Q4
$2.51M Buy
23,864
+20
+0.1% +$1.88K 0.48% 49
2025
Q3
$2M Buy
23,844
+232
+1% +$19.1K 0.38% 64
2025
Q2
$1.87M Sell
23,612
-2,339
-9% -$186K 0.38% 64
2025
Q1
$2.33M Buy
25,951
+1,949
+8% +$182K 0.49% 51
2024
Q4
$2.39M Buy
24,002
+456
+2% +$47K 0.51% 46
2024
Q3
$2.67M Buy
23,546
+522
+2% +$62K 0.57% 45
2024
Q2
$2.85M Sell
23,024
-1,448
-6% -$187K 0.62% 39
2024
Q1
$3.23M Sell
24,472
-550
-2% -$67.8K 0.7% 38
2023
Q4
$2.73M Sell
25,022
-14
-0.1% -$1.45K 0.62% 42
2023
Q3
$2.58M Sell
25,036
-600
-2% -$64.7K 0.64% 40
2023
Q2
$2.96M Sell
25,636
-950
-4% -$108K 0.71% 38
2023
Q1
$2.83M Sell
26,586
-1,000
-4% -$108K 0.69% 38
2022
Q4
$3.06M Sell
27,586
-2,100
-7% -$215K 0.77% 39
2022
Q3
$2.56M Buy
29,686
+104
+0.4% +$9.28K 0.64% 43
2022
Q2
$2.7M Buy
29,582
+1,550
+6% +$137K 0.63% 45
2022
Q1
$2.3M Buy
28,032
+130
+0.5% +$10.2K 0.42% 64
2021
Q4
$2.14M Buy
27,902
+130
+0.5% +$10.4K 0.38% 70
2021
Q3
$2.09M Buy
27,772
+408
+1% +$31K 0.39% 67
2021
Q2
$2.13M Sell
27,364
-504
-2% -$37.5K 0.4% 67
2021
Q1
$2.05M Buy
27,868
+345
+1% +$25.4K 0.41% 63
2020
Q4
$2.15M Buy
27,523
+4,264
+18% +$326K 0.45% 61
2020
Q3
$1.84M Buy
23,259
+786
+3% +$61.6K 0.44% 61
2020
Q2
$1.66M Buy
22,473
+1,152
+5% +$86.7K 0.43% 60
2020
Q1
$1.56M Buy
21,321
+189
+0.9% +$14.9K 0.47% 56
2019
Q4
$1.83M Buy
21,132
+94
+0.4% +$7.72K 0.44% 62
2019
Q3
$1.69M Hold
21,038
0.43% 61
2019
Q2
$1.68M Buy
21,038
+1,964
+10% +$150K 0.44% 61
2019
Q1
$1.51M Sell
19,074
-83
-0.4% -$6.21K 0.41% 65
2018
Q4
$1.4M Buy
19,157
+314
+2% +$22.2K 0.42% 70
2018
Q3
$1.28M Buy
18,843
+513
+3% +$32.7K 0.33% 82
2018
Q2
$1.06M Hold
18,330
0.29% 94
2018
Q1
$953K Buy
18,330
+9,060
+98% +$489K 0.27% 103
2017
Q4
$498K Sell
9,270
-10,632
-53% -$589K 0.28% 103
2017
Q3
$1.22M Buy
19,902
+9,364
+89% +$568K 0.35% 79
2017
Q2
$644K Sell
10,538
-314
-3% -$19.1K 0.39% 75
2017
Q1
$658K Sell
10,852
-121
-1% -$7.34K 0.4% 73
2016
Q4
$616K Sell
10,973
-10,710
-49% -$627K 0.39% 75
2016
Q3
$1.29M Buy
21,683
+453
+2% +$26.5K 0.41% 71
2016
Q2
$1.17M Sell
21,230
-315
-1% -$16.8K 0.39% 78
2016
Q1
$1.09M Buy
21,545
+524
+2% +$25.7K 0.37% 79
2015
Q4
$1.06M Buy
21,021
+10,039
+91% +$506K 0.36% 82
2015
Q3
$518K Sell
10,982
-813
-7% -$43.2K 0.38% 82
2015
Q2
$641K Sell
11,795
-210
-2% -$11.8K 0.43% 67
2015
Q1
$658K Sell
12,005
-471
-4% -$26.7K 0.44% 65
2014
Q4
$676K Buy
12,476
+471
+4% +$26.2K 0.52% 55
2014
Q3
$679K Sell
12,005
-498
-4% -$28K 0.53% 52
2014
Q2
$690K Hold
12,503
0.53% 54
2014
Q1
$677K Buy
+12,503
New +$647K 0.55% 54

Other funds holding MRK

Curbstone Financial Management Corp's MRK Position: Q2 2026 in Review

Curbstone Financial Management Corp increased its Merck (MRK) stake by 3.5% in Q2 2026, buying an estimated $99.5K and bringing the position to 24,914 shares worth $3.2M. The position accounts for 0.55% of the portfolio, ranked #44.

Curbstone Financial Management Corp first reported a position in MRK in Q1 2014 and has held it in 50 quarters since. The position peaked at $3.23M in Q1 2024. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Curbstone Financial Management Corp held 24,914 shares of Merck worth $3.2M as of Q2 2026.
  • Curbstone Financial Management Corp bought 850 Merck shares in Q2 2026, an estimated $99.5K.
  • Merck made up 0.55% of Curbstone Financial Management Corp's portfolio in Q2 2026, its #44 holding.
  • Curbstone Financial Management Corp first reported a position in Merck in Q1 2014 and has held it in 50 quarters since.
  • Curbstone Financial Management Corp's Merck position peaked at $3.23M in Q1 2024.
  • 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Curbstone Financial Management Corp's 13F filing for Q2 2026, filed 14 Jul 2026.